Fifty-five, pensionless and assuming he’d have to work until he died, Roger Ulrich had a decision to make. After two decades in the pharmaceutical industry, his position at Merck & Co. had been phased out.
Takeda Pharmaceutical Co., Asia’s biggest drugmaker, named GlaxoSmithKline Plc’s Christophe Weber as the leading candidate to become its next chief executive officer in a bid to capitalize on the Japanese company’s growing global network.
Sun Pharmaceutical Industries Ltd. said it addressed Food and Drug Administration concerns about quality-control breaches at a U.S. subsidiary that was shut down by the regulator for three years because of manufacturing flaws.
House Republicans say a drugmaker- funded advertising campaign run by supposedly independent groups was part of an agreement with the Obama administration to help pass the U.S. health-care law in 2010.